Treatment of a vasoproliferative tumour with intravitreal bevacizumab (Avastin)

Eye (Lond). 2007 Jun;21(6):893-4. doi: 10.1038/sj.eye.6702782. Epub 2007 Mar 9.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Angiogenesis Inhibitors / therapeutic use*
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab
  • Female
  • Humans
  • Middle Aged
  • Neoplasms, Vascular Tissue / drug therapy*
  • Retinal Neoplasms / drug therapy*

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab